Complete Filing Data
Legend Biotech Corp reported Cash And Cash Equivalents of $901.90 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Legend Biotech Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $414.7M | $413.5M | $382.2M | $335.6M | $313.3M | $232.2M | $161.9M | $60.6M |
| Profit Loss Before Tax | -$282.6M | -$158.1M | -$520.2M | -$445.7M | -$407.2M | -$308.3M | -$130.4M | -$1.6M |
| Profit Loss | -$296.8M | -$177.0M | -$518.3M | -$446.3M | -$403.6M | -$266.4M | -$133.0M | -$2.8M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $190.4M | -$112.5M | $29.6M | $9.8M | $5.2M | $4.1M | $182.0K | -$1.4M |
| Other Comprehensive Income | $190.4M | -$112.5M | $29.6M | $9.8M | $5.2M | $4.1M | $182.0K | -$1.4M |
| Income Tax Expense Continuing Operations | $14.2M | $18.9M | -$1.9M | $625.0K | -$3.6M | -$41.9M | $2.6M | $1.2M |
| Comprehensive Income | -$106.4M | -$289.5M | -$488.7M | -$436.5M | -$398.4M | -$262.3M | -$132.8M | -$4.2M |
| Income Taxes Paid Refund Classified As Operating Activities | $0.00 | $0.00 | -$1.0M | -$3.7M | -$557.0K | -$7.4M | ||
| Profit Loss Attributable To Owners Of Parent | -$177.0M | -$518.3M | -$446.3M | -$403.6M | -$266.4M | -$133.0M | -$2.8M | |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$112.5M | $29.6M | $9.8M | $5.2M | $4.1M | $182.0K | -$1.4M | |
| Cost Of Sales | $397.1M | $216.4M | $144.2M | $65.4M | $0.00 | $0.00 | ||
| Comprehensive Income Attributable To Owners Of Parent | -$289.5M | -$488.6M | -$436.5M | -$398.4M | -$262.3M | -$132.8M | -$4.2M | |
| Collaboration Revenue | $944.8M | $482.6M | $249.8M | $66.7M | $0.00 | $0.00 | ||
| Other Revenue | $6.3M | $179.0K | $328.0K | $3.4M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $901.9M | $286.7M | $1.28B | $786.0M | $688.9M | $455.7M | $83.4M | $210.2M | $2.1M |
| Shortterm Deposits Classified As Cash Equivalents | $0.00 | $100.0K | $400.0K | $1.3M | $1.4M | $384.0K | $256.0K | $255.0K | |
| Rightofuse Assets | $285.2M | $101.9M | $80.4M | $55.6M | $38.3M | $39.5M | $9.3M | $3.7M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $28.6M | $14.1M | $20.1M | $20.9M | $42.2M | $26.3M | $38.6M | $21.0M | |
| Property Plant And Equipment | $116.3M | $99.3M | $108.8M | $105.2M | $102.5M | $72.3M | $70.1M | $28.2M | |
| Cash Flows From Used In Operations Before Changes In Working Capital | -$40.7M | -$198.1M | -$368.2M | -$397.3M | -$361.4M | -$212.5M | -$128.9M | -$12.7M | |
| Cash Flows From Used In Operating Activities | -$100.2M | -$144.0M | -$393.3M | -$201.3M | -$198.5M | -$223.0M | -$83.1M | $307.7M | |
| Cash Flows From Used In Investing Activities | $709.6M | -$850.6M | $92.9M | -$77.1M | -$195.0M | -$24.2M | -$58.7M | -$102.3M | |
| Cash Flows From Used In Financing Activities | -$300.0K | $5.7M | $791.4M | $378.0M | $626.7M | $618.9M | $14.7M | $2.5M | |
| Cash And Cash Equivalents As Stated In Statement Of Financial Position | $901.9M | $286.7M | $1.28B | $786.0M | $688.9M | $455.7M | $83.4M | $210.2M | |
| Cash And Cash Equivalents As Stated In Statement Of Cash Flows | $901.9M | $286.7M | $1.28B | $786.0M | $688.9M | $455.7M | $83.4M | $210.2M | |
| Adjustments For Increase Decrease In Trade And Other Payables | $44.4M | $14.1M | -$50.2M | $72.4M | $1.8M | -$4.3M | $2.0M | $3.2M | |
| Adjustments For Increase Decrease In Other Operating Payables | $36.1M | $43.9M | -$2.7M | $119.3M | $140.7M | $26.9M | $31.7M | $18.3M | |
| Adjustments For Depreciation Of Right Of Use Assets | $19.5M | $10.7M | $7.8M | $5.7M | $4.4M | $3.5M | $1.2M | $823.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$5.7M | $93.8M | -$99.0M | $50.3M | $24.6M | -$45.0M | -$3.8M | $207.6M | |
| Adjustments For Decrease Increase In Prepayments Other Receivable Other Assets | -$126.8M | -$61.7M | -$8.7M | -$50.6M | -$3.0M | $3.4M | -$3.9M | -$2.5M | |
| Interest On Lease Payments Classified As Operating Activities | -$1.8M | -$1.4M | -$527.0K | -$142.0K | -$195.0K | -$199.0K | -$82.0K | ||
| Cash Flows From Used In Operations | -$178.1M | -$439.5M | -$210.0M | -$199.5M | -$233.3M | -$76.4M | $306.0M | ||
| Other Payables And Accruals Current | $195.4M | $166.2M | $122.3M | $184.1M | $123.6M | $99.2M | $70.9M | ||
| Noncurrent Liabilities | $95.2M | $351.9M | $380.8M | $288.9M | $124.3M | $279.6M | $282.8M | ||
| Noncurrent Lease Liabilities | $87.2M | $44.6M | $44.2M | $20.0M | $1.6M | $1.9M | $5.1M | ||
| Noncurrent Assets | $486.6M | $386.3M | $350.8M | $231.8M | $169.6M | $128.1M | $80.6M | ||
| Liabilities | $731.6M | $629.6M | $597.2M | $586.7M | $353.5M | $440.8M | $410.6M | ||
| Equity And Liabilities | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $721.0M | $287.7M | ||
| Current Trade Receivables | $13.1M | $6.4M | $100.0M | $90.0K | $50.4M | $75.0M | $30.0M | ||
| Current Prepayments And Other Current Assets | $253.4M | $131.0M | $69.3M | $61.8M | $13.9M | $10.0M | $16.8M | ||
| Current Liabilities | $636.4M | $277.7M | $216.4M | $297.8M | $229.2M | $161.2M | $127.8M | ||
| Current Lease Liabilities | $7.4M | $4.8M | $3.2M | $3.6M | $911.0K | $1.5M | $1.0M | ||
| Current Assets | $1.25B | $1.28B | $1.50B | $1.10B | $949.9M | $592.9M | $207.1M | ||
| Assets | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $721.0M | $287.7M | ||
| Other Noncurrent Nonfinancial Assets | $12.4M | $13.0M | $1.5M | $1.5M | $5.1M | $4.0M | |||
| Cash Received From Withdrawal Of Financial Assets At Fair Value Through Profit Or Loss | $0.00 | $149.2M | $185.0M | $100.0M | $50.1M | $22.7M | $320.9M | ||
| Cash Receipts Of Investment Income Classified As Investing Activities | $0.00 | $2.5M | $8.9M | $1.3M | $0.00 | $47.0K | |||
| Intangible Assets Other Than Goodwill | $2.2M | $4.1M | $3.4M | $4.7M | $2.9M | $519.0K | |||
| Gains Losses On Disposals Of Property Plant And Equipment | -$2.0K | -$226.0K | -$481.0K | -$974.0K | -$55.0K | ||||
| Deferred Government Grant | -$565.0K | -$628.0K | -$307.0K | -$295.0K | -$114.0K | ||||
| Prepayment To Collaborator For Collaboration Right Of Use Assets | $54.9M | $98.8M | $14.8M | $1.7M | $19.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $3.6M | $4.0M | $3.8M | $2.6M | $1.4M | $2.6M | $5.1M | $219.0K |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $6.1M | -$2.1M | $700.0K | -$2.5M | $34.0K | $620.0K | $249.0K | $124.0K |
| Proceeds From Exercise Of Options | $3.3M | $9.7M | $11.8M | $2.9M | $4.6M | $1.5M | ||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$988.9M | $491.0M | $99.6M | $233.2M | $371.7M | -$127.1M | $207.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 | $-1.13 | $-0.66 | $-0.01 |
| Basic Earnings Loss Per Share | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 | $-1.13 | $-0.66 | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Selling And Distribution Expenses | $205.8M | $147.5M | $94.2M | $93.4M | $102.5M | $49.6M | $25.6M | $1.2M |
| Finance Costs | $21.4M | $21.6M | $21.8M | $10.8M | $900.0K | $4.2M | $223.0K | $82.0K |
| Administrative Expense | $135.8M | $136.8M | $106.8M | $80.6M | $47.0M | $23.1M | $6.8M | $2.8M |
| Other Reserves | $1.00B | $1.04B | $1.25B | $744.0M | $766.0M | $597.7M | ||
| Increase Decrease Through Sharebased Payment Transactions | $64.6M | $68.9M | $47.7M | $34.3M | $20.2M | $4.8M | $1.3M | $704.0K |
| Finance Income Received Classified As Operating Activities | $52.0M | $37.3M | $47.3M | $5.6M | $652.0K | $3.4M | $9.0M | $1.8M |
| Expense From Sharebased Payment Transactions With Employees | $64.6M | $68.9M | $47.7M | $34.3M | $20.2M | $4.8M | $1.3M | $704.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $168.8M | -$109.3M | $28.2M | $9.2M | $4.9M | -$66.0K | -$250.0K | -$7.2M |
| Adjustments For Finance Income | $40.1M | $61.2M | $54.5M | $8.2M | $971.0K | $2.9M | $4.6M | $6.2M |
| Adjustments For Finance Costs | $21.4M | $21.6M | $21.8M | $10.8M | $900.0K | $4.2M | $223.0K | $82.0K |
| Adjustments For Depreciation Expense | $9.4M | $10.7M | $10.7M | $10.2M | $8.1M | $6.2M | $4.0M | $845.0K |
| Adjustments For Decrease Increase In Inventories | -$4.5M | -$17.2M | -$12.7M | -$13.9M | $51.0K | -$643.0K | -$22.0K | -$1.1M |
| Times Deposits Current And Noncurrent | $46.7M | $840.3M | $34.7M | $54.0M | $168.2M | $50.0M | $75.6M | |
| Increase Decrease Through Exercise Of Options | $3.3M | $9.8M | $11.8M | $2.9M | $4.6M | $1.5M | ||
| Adjustments For Fair Value Gains Losses | $0.00 | $0.00 | -$700.0K | -$593.0K | $0.00 | -$47.0K | -$474.0K | -$89.0K |
| Adjustments For Amortisation Expense | $1.9M | $1.9M | $2.5M | $1.4M | $192.0K | $63.0K | $15.0K | |
| Issued Capital | $100.0K | $100.0K | $36.0K | $33.0K | $31.0K | $27.0K | $20.0K | |
| Inventories | $32.0M | $23.9M | $19.4M | $10.4M | $1.7M | $1.8M | $1.2M | |
| Addition In Time Deposits | $4.54B | $2.56B | $4.86B | $370.0M | $298.1M | $50.0M | $75.6M | |
| Other Expense By Nature | $40.0K | $28.5M | $9.8M | $9.1M | $346.0K | $221.0K | $2.0K | |
| Times Deposits | $46.7M | $835.9M | $30.3M | $54.0M | $163.5M | $50.0M |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.